Correction: 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: 41BB-based and CD28-based CD123-redirected T-cells Ablate Human Normal Hematopoiesis in Vivo. BMJ Publishing Group.
MLA (9th ed.) CitationCorrection: 41BB-based and CD28-based CD123-redirected T-cells Ablate Human Normal Hematopoiesis in Vivo. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.